Skip to content
Screener

Insmed INSM Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$120.85M-15.5%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$20.67M-10.7%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$370K+208%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$21.93M-17.2%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
$915K-39.4%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$10.38M+490%

Other financials

Income statement

See full
Revenue$425.5M+296%
Gross profit$358.3M+352%
Operating income-$1.5M+99.5%
Net income-$13.2M+95.9%
EPS (diluted)-$0.06+96.5%

Balance sheet

See full
Cash & equivalents$544.8M-57.6%
Total debt$579.9M+0.8%
Total equity$757.5M-39.4%
Total assets$2.1B-15.2%

Cash flow

See full
Operating cash flow-$88.8M+56.8%
CapEx$6.3M+79.6%
Free cash flow-$95.1M+54.5%

Valuation

See full
Market cap$29.43B+23.3%
Enterprise value$29.46B+27.2%
P/S25.9×-34.1×

Profitability

See full
Gross margin83.5%+7.7pp
Operating margin-73.9%-30.6pp
Net margin-76.9%-31.8pp
FCF margin-71%-28.6pp

Returns & leverage

See full
Return on equity-87.2%-27.3pp
Debt / equity0.8×+0.3×
Current ratio3.7×-3.0×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Insmed’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:59 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104506-26-000041
Line itemAs of / June 30, 2026As of / December 31, 2025
Total current assets1,633,9191,794,208
Fixed assets, net107,219102,942
Finance lease right-of-use assets14,20515,561
Operating lease right-of-use assets13,17920,708
Intangibles, net93,48997,651
Goodwill136,110136,110
Other assets104,44497,378
Total assets$2,102,565$2,264,558

Item 1C. Consolidated Financial Statements

FAQ

What is Insmed's operating lease ROU assets?
Insmed (INSM) reported operating lease ROU assets of $13.18M in Q2 2026.
How has Insmed's operating lease ROU assets changed year-over-year?
Insmed's operating lease ROU assets increased by 27.8% year-over-year, from $10.32M to $13.18M.
What is the long-term trend for Insmed's operating lease ROU assets?
Over 5 years (2020 to 2025), Insmed's operating lease ROU assets has grown at a -8.9% compound annual growth rate (CAGR), from $32.95M to $20.71M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Insmed's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude